Journal Mobile Options
Table of Contents
Vol. 47, No. 2, 1987
Issue release date: 1987
Psychother Psychosom 1987;47:101–104
(DOI:10.1159/000288004)

Electrodermal Activity in Low and High Alexithymia Neurotic Patients

Rabavilas A.D.
Department of Psychiatry, Athens University Medical School, Eginition Hospital, Athens, Greece

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

This study explores the relations between alexithymia and level of arousal in patients suffering from anxiety states. Among 105 patients investigated, two groups were finally identified by means of the Schalling-Sifneos Personality Scale; a group of patients with ‘low’ and a group with ‘high’ alexithymia. These groups underwent a psychophysiological assessment concerning electrodermal activity measures recorded during resting and stimulation periods. The results suggested that high alexithymia patients demonstrated significantly higher levels of electrodermal arousal and slower recovery time in novel situations as compared with low alexithymia patients. These findings support the view that an exacerbated degree of arousal may be an important factor with respect to the development of alexithymia, even in a nonpsychosomatic population.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00